Trial Profile
Therapy of Pulmonary Arterial Hypertension (PAH) With Bosentan in Patients With Eisenmenger Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 06 Nov 2015 New trial record